ADMA
NASDAQ · Biotechnology
Adma Biologics Inc
$8.70
+0.01 (+0.12%)
ADMA News7 articles
Plug Power Shares Slide as Investors Eye Profitability Roadmap
Plug Power shares slid nearly 3% as the company detailed its timeline to profitability through 2028, with investors weighing cash burn and liquidity concerns.
D-Wave Quantum Shares Dip as Gate-Model Roadmap Unveiled Amid Dilution Concerns
D-Wave Quantum shares slipped 1.37% premarket to $29.50 after announcing a gate-model quantum roadmap targeting 100 logical qubits by 2032, while investors assess dilution risks and revenue challenges.
D-Wave Quantum Stock Wavers After Laying Out 2032 Gate-Model Roadmap
D-Wave shares erased early gains to close flat after unveiling a gate-model roadmap targeting 100 logical qubits by 2032. Analysts raised price targets, but revenue fell 81% and a $100M grant is pending.
D-Wave Quantum Outlines Gate-Model Roadmap Targeting 100 Logical Qubits by 2032
D-Wave Quantum shares rose 1.2% to $30.50 after unveiling a gate-model roadmap targeting 100 logical qubits by 2032, with a 17-physical-qubit system planned for 2026.
TSMC Delays High-NA EUV Adoption, Unveils A13 and N2U Roadmap
TSMC introduced its A13 chip technology and a new 2-nanometer variant called N2U, while confirming it will postpone adoption of ASML's advanced High-NA EUV lithography systems until at least 2029.
Nvidia Gains Ahead of GTC as Investors Await AI Roadmap Details
Nvidia shares advanced Monday ahead of CEO Jensen Huang's keynote at the GTC conference, where details on new AI chips and inference strategy are anticipated.
Nvidia Eyes GTC Conference for AI Roadmap Amid Investor Scrutiny
Nvidia shares traded around $183, with attention turning to next week's GTC conference for potential AI catalysts. The chipmaker recently reported a 73% revenue surge but faces questions on spending and rivals.